Cargando…
Expression, prognostic significance and therapeutic implications of PD‐L1 in gliomas
The advent of checkpoint immunotherapy, particularly with programmed death‐1 (PD‐1) and programmed death‐ligand 1 (PD‐L1) inhibitors, has provided ground‐breaking results in several advanced cancers. Substantial efforts are being made to extend these promising therapies to other refractory cancers s...
Autores principales: | Vimalathas, Gayaththri, Kristensen, Bjarne Winther |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298327/ https://www.ncbi.nlm.nih.gov/pubmed/34533233 http://dx.doi.org/10.1111/nan.12767 |
Ejemplares similares
-
The Prognostic and Therapeutic Value of PD-L1 in Glioma
por: Chen, Ruo Qiao, et al.
Publicado: (2019) -
The prognostic significance of PD-L1 expression in patients with glioma: A meta-analysis
por: Xue, Song, et al.
Publicado: (2017) -
Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer
por: Zhu, Xinxin, et al.
Publicado: (2017) -
Expression and prognostic value of the transcription factors EGR1 and EGR3 in gliomas
por: Knudsen, Arnon Møldrup, et al.
Publicado: (2020) -
Prognostic implications of PD-L1 expression in patients with angiosarcoma
por: Lee, Jii Bum, et al.
Publicado: (2021)